IL13 and neoplasm: Activation of MDSCs not only requires tumour-derived factors (e.g., tumour-derived prostaglandin E2 (PGE2)) but also IFN-γ produced by T cells and factors secreted by tumour stromal cells (like IL-1β, IL-4, IL-6, IL-10, IL-13).